type 2 diabetesGLP-1RAs
…rporate Data Warehouse.Participants Veterans Affairs users with type 2 diabetes who started treatment with GLP-1RAs (n=132 551) or sulfonylurea…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 25 of 2459sodium glucose cotransporter 2 inhibitorschronic kidney diseasechronic kidney disease2cardiovascular diseasenon-steroidal mineralocorticoid antagonistskidney failureangiotensin converting enzyme inhibitorsBMJ Medicinediabetes
…ion novel drug treatments for chronic kidney disease, including sodium glucose cotransporter 2 inhibitors and non-steroidal mineralocorticoid antagonists. Research and h…
Ficerafusp alfacetuximabColorectal cancerCRC
…n and cytolytic activity of PBMCs against SNU-503 and NCI-H508. Ficerafusp alfa showed prolonged and significantly improved tumor cytotoxicity …
semaglutide
…native treatments. Some PROs indicated greater improvement with semaglutide versus alternative treatment. No new safety concerns were ident…
rituximabobinutuzumab
…ies rendering it capable of superior B-cell killing compared to rituximab.5 The NOBILITY trial, a phase 2 clinical trial in patients with…
Autoimmune hepatitisVitamin DAIH
…d 2025 Jun 5];13(4):709.Kilani Y, Alsakarneh S, Madi MY, et al. Autoimmune hepatitis and vitamin D deficiency: a nationwide perspective. Aliment Pha…
Thoracic outlet syndromeVisual Analogue ScaleTOShyaluronidase
… Dierks G, Vervaeke HE, Jumonville A, Kaye AD, Myrcik D, et al. Thoracic outlet syndrome: a narrative review. J Clin Med. 2021;10(5):962.Demondion X, He…
sildenafilWhipple’s diseaseTadalafilsarcoidosis
…on of sarcoidosis, another cause of PH, and the side effects of sildenafil. This case demonstrates the diagnostic complexity of PH complic…
docetaxelatezolizumabbevacizumab
…arm, 7.5% in the atezolizumab+bevacizumab arm, and 15.4% in the docetaxel (control) arm. There were no clear correlations of response or …
cannabisnicotineMedical University of South Carolina
… brief counselling and SMS-text based cessation support whereas cannabis use is monitored but not treated. Biochemical verification (thr…
tirzepatideorforglipronphentermine-topiramateCagriSemanaltrexone-bupropionSubcutaneous semaglutidemazdutideliraglutide
… with naltrexone-bupropion, oral semaglutide, orforglipron, and tirzepatide (risk ratios from 3.1 to 4.2). Fatigue risk increased, particul…